Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Enanta Pharmaceuticals (ENTA) Interest Coverage Ratio (2016 - 2025)

Enanta Pharmaceuticals (ENTA) has disclosed Interest Coverage Ratio for 9 consecutive years, with 3.65 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Interest Coverage Ratio rose 69.58% year-over-year to 3.65, compared with a TTM value of 8.3 through Dec 2025, up 28.84%, and an annual FY2025 reading of 11.11, changed 0.11% over the prior year.
  • Interest Coverage Ratio was 3.65 for Q4 2025 at Enanta Pharmaceuticals, up from 7.7 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 3.65 in Q4 2025 and bottomed at 18.38 in Q2 2023.
  • Average Interest Coverage Ratio over 3 years is 11.12, with a median of 11.57 recorded in 2024.
  • The sharpest move saw Interest Coverage Ratio fell 18.36% in 2024, then skyrocketed 69.58% in 2025.
  • Year by year, Interest Coverage Ratio stood at 10.14 in 2023, then fell by 18.36% to 12.0 in 2024, then surged by 69.58% to 3.65 in 2025.
  • Business Quant data shows Interest Coverage Ratio for ENTA at 3.65 in Q4 2025, 7.7 in Q3 2025, and 11.68 in Q2 2025.